The mature analgesics category saw some signs of revival during 2016 and 2017. Better value growth was achieved by two new categories becoming available in OTC form in late 2015-2016. Adult naproxen and triptans obtained LVI status (an OTC product that requires consultation with a pharmacist). These status changes had a positive impact on overall sales of analgesics. OTC naproxen and triptans are offered for emergency use, and therefore they have notably higher unit prices than the same brands p...BRBREuromonitor International's Analgesics in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.BRBRProduct coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic. BRBRData coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.BRBRWhy buy this report?ULLI Get a detailed picture of the Analgesics market;/LILI Pinpoint growth sectors and identify factors driving change;/LILI Understand the competitive environment, the market’s major players and leading brands;/LILI Use five-year forecasts to assess how the market is predicted to develop./LI/ULBRBREuromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.